未登录

M

Mark C. Willingham

biotechnology and biological sciences research council (bbsrc)

H指数:99

被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regulation of β-catenin by a novel nongenomic action of thyroid hormone β receptor

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2790

OAAI

Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2726

OAAI

An unliganded thyroid hormone p receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27105

OAAI

Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer

ENDOCRINE-RELATED CANCER

IF4.6

2020-04-0115

OA

Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer

ENDOCRINE-RELATED CANCER

IF4.6

2018-10-0128

OAAI

Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene

IF3.7

2017-09-1424

OAAI

Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2017-03-2835

OAAI

SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model

ENDOCRINE-RELATED CANCER

IF4.6

2016-07-017

OA

Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor

Y406处酪氨酸磷酸化的丧失消除了甲状腺激素受体的肿瘤抑制功能

MOLECULAR CARCINOGENESIS

IF3.2

2016-06-147

OAAI

Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model

ENDOCRINE-RELATED CANCER

IF4.6

2015-11-0936

OAAI

DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer

DMP1β，肿瘤抑制基因DMP1位点的剪接异构体，诱导乳腺癌的增殖和进展

JOURNAL OF PATHOLOGY

IF5.2

2015-02-0928

OAAI

Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity

IF2.9

2015-01-0931

OAAI

Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation

IF7.7

2014-09-0145

OAAI

Inhibition of Tumorigenesis by the Thyroid Hormone Receptor β in Xenograft Models

IF6.7

2014-02-0145

OAAI

Role of DMP1 and its future in lung cancer diagnostics

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2014-01-0923

OAAI

A histone deacetylase inhibitor improves hypothyroidism caused by a TR1 mutant

HUMAN MOLECULAR GENETICS

IF3.2

2013-12-3021

OA

Is Wilms Tumor a Candidate Neoplasia for Treatment with WNT/β-Catenin Pathway Modulators?-A Report from the Renal Tumors Biology-Driven Drug Development Workshop

MOLECULAR CANCER THERAPEUTICS

IF5.5

2013-12-0529

OA

Diet-Induced Obesity Increases Tumor Growth and Promotes Anaplastic Change in Thyroid Cancer in a Mouse Model

IF3.3

2013-08-0162

OA

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

免疫，增殖和分子亚型在乳腺癌预后中的相互作用

IF9.4

2013-04-29154

OAAI

Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2013-04-2237

OAAI